Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Clinical Trial to Evaluate the Use of Genotype-based Dosing of Voriconazole

NCT06510699 is registered in ClinicalTrials.gov with The University of Queensland as lead sponsor.

NCT NCT06510699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06510699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Clinical Trial to Evaluate the Use of Genotype-based Dosing of Voriconazole
Lead sponsor
The University of Queensland
Phase
Phase 2
Overall status
Recruiting
Start date
April 14, 2025
Completion date
March 26, 2027
Enrollment
104 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

blood cancer, fungal infection, haematological malignancy, infectious disease